SI
KURA icon

Sofinnova Investments’s Kura Oncology KURA Stock Holding History

Sofinnova Investments’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-791,667
Closed -$5.23M – 73
2025
Q1 		$5.23M Buy
+791,667
New +$6.17M 0.34% 52
2024
Q4 		– Sell
-296,884
Closed -$5.8M – 70
2024
Q3 		$5.8M Sell
296,884
-528,359
-64% -$10.7M 0.46% 40
2024
Q2 		$17M Buy
825,243
+323,303
+64% +$6.65M 0.88% 35
2024
Q1 		$10.7M Sell
501,940
-1,165,381
-70% -$22.7M 0.6% 37
2023
Q4 		$24M Buy
+1,667,321
New +$16.4M 1.34% 20
2023
Q2 		– Sell
-616,169
Closed -$7.54M – 58
2023
Q1 		$7.54M Buy
616,169
+22,608
+4% +$282K 0.48% 36
2022
Q4 		$7.37M Buy
+593,561
New +$8.63M 0.44% 33
2022
Q1 		– Sell
-369,173
Closed -$5.17M – 74
2021
Q4 		$5.17M Sell
369,173
-385,948
-51% -$6.25M 0.3% 55
2021
Q3 		$14.1M Buy
755,121
+310,749
+70% +$5.86M 0.84% 32
2021
Q2 		$9.27M Buy
444,372
+361,208
+434% +$8.97M 0.53% 41
2021
Q1 		$2.35M Sell
83,164
-37,513
-31% -$1.19M 0.14% 60
2020
Q4 		$3.94M Sell
120,677
-104,582
-46% -$3.67M 0.23% 54
2020
Q3 		$6.9M Sell
225,259
-385,720
-63% -$8.52M 0.51% 34
2020
Q2 		$9.96M Buy
+610,979
New +$8.81M 0.63% 37
2018
Q4 		– Sell
-247,385
Closed -$4.33M – 67
2018
Q3 		$4.33M Buy
247,385
+79,485
+47% +$1.52M 0.39% 41
2018
Q2 		$3.06M Buy
+167,900
New +$2.84M 0.35% 46

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sofinnova Investments's KURA Position: Q2 2025 in Review

Sofinnova Investments sold out of Kura Oncology (KURA) in Q2 2025, closing a stake of 791,667 shares — an estimated $5.23M sold.

Sofinnova Investments first reported a position in KURA in Q2 2018 and held it in 16 quarters. The position peaked at $24M in Q4 2023. 182 funds tracked by Wall St. Rank hold KURA as of Q2 2025.

  • Sofinnova Investments reported no remaining Kura Oncology position as of Q2 2025 after selling out during the quarter.
  • Sofinnova Investments sold 791,667 Kura Oncology shares in Q2 2025, an estimated $5.23M.
  • Sofinnova Investments first reported a position in Kura Oncology in Q2 2018 and held it in 16 quarters.
  • Sofinnova Investments's Kura Oncology position peaked at $24M in Q4 2023.
  • 182 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2025.

Based on Sofinnova Investments's 13F filing for Q2 2025, filed 14 Aug 2025.